Publication date: Aug 08, 2019
A new study supports limiting the use of brain MRI scans using gadolinium-based contrast agents for purposes of monitoring multiple sclerosis disease activity. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
- GBCA-enhanced MRI does not influence MS progression
- Study Examines Gadolinium Deposits in MS Patients’ Brains, But Still Can’t Determine Relationship with Disease Severity
- The effects of clinical pilates training on walking, balance, fall risk, respiratory, and cognitive functions in persons with multiple sclerosis: a randomized controlled trial – Abas ıyanık Z, Ertekin cD6, Kahraman T, Yigit P, cD6zakbaş S
- Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.